GlassScriptPhysician profile
Justin B Heller
NPI 1639373590
$1,854.52
in general payments reported to CMS, 2019-2025
15 companies · $363 in 2025
The $363 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $45.65 · 2022: $129 · 2023: $792 · 2024: $158 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $845.02 | 2022-2025 | Xeomin |
| Nevro Corp. | $195.13 | 2023 | Senza |
| Medtronic, INC. | $190.07 | 2023-2025 | Intellis Adaptivestim |
| Apyx Medical Corporation | $154.82 | 2019 | |
| Axogen | $139.41 | 2019-2023 | Avance Nerve Graft |
| Musculoskeletal Transplant Foundation INC. | $90.47 | 2019 | |
| Revance Therapeutics, INC. | $77.51 | 2025 | Daxxify |
| Motiva USA, LLC | $26.67 | 2025 | |
| Integra Lifesciences Corporation | $24.46 | 2020 | |
| Stryker Corporation | $22.99 | 2022 | |
| Acell, INC. | $21.19 | 2020 | |
| Galderma Laboratories, L.P. | $20.00 | 2025 | |
| Allergan, INC. | $18.07 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.25 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Tei Biosciences INC | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Heller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.